TFRI News|November 12, 2024 Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer.
Research Highlight|October 30, 2024 Drug discovery could prevent spread of childhood bone cancer A team of TFRI-funded researchers at the University of British Columbia identified a potential drug that could halt the spread of osteosarcoma.
Research Highlight|October 30, 2024 Researchers develop promising therapy treatment that can kill glioblastoma cells in newly discovered brain pathway A team of Canadian and US-based research groups co-led by the Singh Lab at McMaster University have discovered a new pathway that is used by cancer ce...
TFRI News|October 30, 2024 Researchers raise more than $157k for cancer research in 2024 Terry Fox Run Challenge TFRI-funded researchers raised $157,874 as part of this year’s Terry Fox Run Challenge – an annual competition among Terry Fox-funded researchers to d...
TFRI News|October 30, 2024 TFRI partners with the Canadian Cancer Society to co-fund four Research Training Awards The Terry Fox Research Institute has once again partnered with the Canadian Cancer Society (CCS) to co-fund two PhD students and two postdoctoral fell...
Research Highlight|October 30, 2024 Identifying immune patterns to personalize ovarian cancer therapy Immunotherapy, which harnesses the body’s natural defense against cancer, has shown success in some cancers, but so far, it hasn’t been successful for...
Research Highlight|October 30, 2024 Decoding the spread of lung cancer Lung adenocarcinoma (LUAD), a leading cause of cancer-related deaths, may have met its match in the form of a tiny chemical tag known as m6A methylati...
Research Highlight|October 30, 2024 No tumour sample, no problem: Blood test predicts immunotherapy outcomes without biopsy A blood test developed by Terry Fox-funded researchers has shown the potential to predict how patients with various types of cancer will respond to im...
Research Highlight|October 30, 2024 Scientists discover high-risk form of endometrial cancer – and how to test for it – using AI A discovery by researchers at the University of British Columbia (UBC), funded in part by the Terry Fox Research Institute, promises to improve care f...
TFRI News|October 01, 2024 TFRI welcomes Sema Burney to its Board of Directors, with Dr. John Bell taking on new role as chair The Terry Fox Research Institute (TFRI) recently made updates to its Board of Directors. Dr. John Bell, a driving force in the development of virus-ba...
TFRI News|September 18, 2024 TFRI research community pays tribute to Dr. Philip Branton, extraordinary builder, leader and collaborator TFRI’s leadership and research community are deeply saddened to learn of the recent passing of Dr. Philip (Phil) Branton, who dedicated his life to ca...
TFRI News|September 10, 2024 TFRI reaches record high of 20 active PPGs with nearly $20 million awarded to four teams in 2024 competition for prestigious Terry Fox New Frontiers Program Project Grants Four Canadian research teams will receive a total of $19.8 million in new and renewal funding to advance cancer research and improve treatments as the...
Event|June 27, 2024 Register now for the 2024 Terry Fox Run and join TFRI's Run Challenge! To celebrate Terry’s incredible journey, we invite you to register for this year’s Terry Fox Run, scheduled for Sunday, September 15, and take part in...
Event|June 07, 2024 TFRI's 10th Scientific Meeting brings cancer researchers, patients and oncologists from across Canada to Toronto The Terry Fox Research Institute’s 10th Scientific Meeting, titled Accelerating Collaborations in Cancer Research, was held on May 24-26 in Toronto.
Press Release|May 30, 2024 Leading Terry Fox-Funded Scientists Forge a New Era in Cancer Research Over 100 Canadian cancer researchers signed an open letter calling for accelerated collaborations and urgent support, in order to end cancer as we kno...
TFRI News|May 30, 2024 THIS IS THE BEGINNING OF THE END FOR CANCER AS WE KNOW IT. Canada’s leading cancer scientists hail the start of a golden age in research and call for accelerated collaborations between doctors, scientists, and...
TFRI News|April 15, 2024 2025 funding competitions are open! The Terry Fox Research Institute is pleased to announce the launch of its 2025 cancer research programs, funded by the Terry Fox Foundation.
TFRI News|March 25, 2024 The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu on being elected president of the American Association for Cancer Research The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu on being elected president of the Americ...
TFRI News|March 09, 2024 Honouring Dr. Connie Eaves: Stem Cell Pioneer Dr. Connie Eaves leaves a lasting legacy as an international leader in stem cell research, bone marrow transplantation and treatments for leukemia and...
TFRI News|February 14, 2024 Seven outstanding early-career researchers named 2024 Terry Fox New Investigators Seven talented, early-career scientists in Ontario, Quebec and British Columbia will each receive $450,000 over the next three years to support impact...
TFRI News|February 12, 2024 Celebrating International Day of Women and Girls in Science Meet Dr. Isabel Serrano, managing director of the Marathon of Hope Cancer Centres Network.
TFRI News|January 26, 2024 TFRI supports the next generation of cancer researchers in Canada The Terry Fox Research Institute has co-funded six Master’s and PhD students and one postdoctoral fellow as part of the Canadian Cancer Society’s inau...
TFRI News|January 25, 2024 TFRI announces new leadership appointment for Marathon of Hope Cancer Centres Network TFRI is pleased to announce that Dr. Isabel Serrano has been appointed to position of managing director of the Marathon of Hope Cancer Centres Network...
Research Highlight|December 14, 2023 Study finds new clinical trial drug boosts ability of oncolytic virus to target and kill cancer Researchers at The Ottawa Hospital have identified a method to boost the activity of cancer-fighting viruses by pairing one with a new cancer drug cur...
Research Highlight|December 14, 2023 BC team identifies drivers of aggressive childhood cancers and develops model to explore new treatments A team of BC-based researchers verified two drivers of cancerous tumours caused by DICER1 syndrome and developed an animal model that will allow them ...
Press Release|December 14, 2023 uOttawa research team reveals new insights into chemotherapy resistance With funding from a Terry Fox Program Project Grant, researchers at the University of Ottawa found that exposing cancer cells to sublethal doses of ch...
Research Highlight|December 14, 2023 Study finds smoking tobacco causes mutations that directly disable the genes protecting us from cancer Toronto-based researchers funded by The Terry Fox Research Institute have discovered one way smoking tobacco weakens the body’s natural defences and l...
Research Highlight|December 14, 2023 New findings reveal novel biomarker can predict success of immunotherapy A team of Montreal-based researchers discovered a novel biomarker that can help them predict which patients are most likely to benefit from immune che...
TFRI News|December 14, 2023 Dedicated cancer researchers raise more than $156k for research Terry Fox-funded researchers across Canada donned purple shirts for the 43rd annual Terry Fox Run in September and raised more than $156,000 for cance...
TFRI News|December 14, 2023 Canadian scientists John Bell and Linda Penn and former media executive Wendy Freeman appointed to TFRI’s Board of Directors TFRI recently welcomed three new members to its Board of Directors. Two are well known and leading Canadian cancer researchers who have also been fund...
Press Release|October 24, 2023 Blood test detects tumours early in families with cancer Researchers funded by The Terry Fox Research Institute have demonstrated that by analyzing patients’ blood samples, they are able to detect cancer ear...
TFRI News|August 17, 2023 Five new research teams named recipients of the 2023 Terry Fox New Frontiers Program Project Grants Five outstanding Canadian research teams will receive a total of $12 million to advance cancer research and treatment following new awards in the 2023...
TFRI News|August 17, 2023 We’re growing! Meet our newest team members We are pleased to welcome two new team members to our Vancouver office!
TFRI News|August 16, 2023 Register now for the 2023 Terry Fox Run! We hope you will consider registering for the run, fundraising for the Terry Fox Foundation and joining our annual Run Challenge. As Terry said back i...
Research Highlight|August 16, 2023 PROJECT UPDATE: Targeting metabolic vulnerabilities to improve cancer therapy A longstanding Terry Fox New Frontiers Program Project Grant team has come to understand that the process of cancer metabolism is not only central to ...
Research Highlight|August 16, 2023 In anticipation of the 2023 Terry Fox Run, Drs. Livia Garzia and Michael Monument discuss sarcoma research in Canada Funding from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer Centres Network (MOHCCN) is addressing research gaps to bring new...
Research Highlight|August 16, 2023 Researchers develop imaging method to study pancreatic cancers and their surrounding environment in real time A Toronto-based research team partially funded through a Terry Fox New Investigator Award to Dr. Ralph DaCosta has developed an innovative imaging pla...
Research Highlight|July 10, 2023 Terry Fox New Investigator finds that fecal transplants show promise in improving melanoma treatment In a first-of-its-kind Canadian clinical trial a group of researchers found that fecal microbiota transplants (FMT) are safe and show promise in impro...
Research Highlight|June 27, 2023 A Q&A with prostate cancer researcher Dr. Amina Zoubeidi TFRI reached out to prostate cancer researcher Dr. Amina Zoubeidi to learn more about her cancer research journey, the lessons she’s learned along the...
Research Highlight|June 22, 2023 Study reveals cause for different outcomes for patients that experience early and late relapse of diffuse large B-cell lymphoma A recent study sheds light on the cause behind the different outcomes of patients with diffuse large B cell lymphoma (DLBCL) who experienced a relapse...
Research Highlight|June 22, 2023 Une nouvelle étude révèle qu’un acide aminé pourrait servir au traitement de certains cancers agressifs Une étude conjointe menée sur trois ans par des scientifiques de l’Université McGill et de l’Université de Colombie-Britannique et financée en partie ...
Research Highlight|June 22, 2023 New study identifies amino acid to potentially treat aggressive cancers The dietary supplement alanine has been found to be effective in the treatment of aggressive cancers in preclinical models, such as small cell carcino...
Research Highlight|May 09, 2023 Novel strategy to penetrate cancer cell wall yields 25-fold increase in porphyrin uptake, improving photodynamic therapy and potential drug delivery TFRI-funded researchers have developed a novel strategy to penetrate the cancer cell wall yielding a 25-fold increase in porphyrin uptake, improving p...
Research Highlight|May 09, 2023 Scientists find Li-Fraumeni syndrome defined by more than one gene; expansion of genetic and epigenetic testing will benefit patients Scientists at The Hospital for Sick Children in Toronto find Li-Fraumeni syndrome may be defined by more than one gene, highlighting the benefits of e...
Research Highlight|May 09, 2023 Pan-Canadian multiple myeloma study recruits 95 patients, finds those resistant to immunotherapy show T-cell exhaustion signatures The pan-Canadian, TFRI-funded Multiple Myeloma Molecular Monitoring (M4) Study makes progress as researchers recruit 95 patients and find that those r...
Research Highlight|May 09, 2023 PROJECT UPDATE: A Q&A with Dr. Jeanette Boudreau, Halifax-based Terry Fox New Investigator, on harnessing the power of natural killer cells for immunotherapy in ovarian cancers We interviewed Dr. Jeanette Boudreau, a Halifax-based Terry Fox New Investigator who has identified a panel of markers that can be used to define natu...
Research Highlight|May 09, 2023 Study mimicking brain development identifies protein linked to neurodevelopmental disorders A TFRI-funded team based at the Princess Margaret Cancer Centre have identified a protein called RuvB-like 2 (RUVBL2) linked to certain rare neurodeve...
Research Highlight|May 09, 2023 Investigators explore how acute myeloid leukemia (AML) therapies can be tailored to individuals To better predict which acute myeloid leukemia (AML) therapy would be best suited for each patient, a team of researchers at Princess Margaret Cancer ...
TFRI News|May 09, 2023 TFRI is growing! Meet our newest team members and see who has taken on new roles We are pleased to welcome two new team members to our Vancouver office and announce a new role for a member of the TFRI communications team!
TFRI News|May 09, 2023 Terry Fox Run registration is open! Drs. Jim Woodgett and André Veillette share what research teams need to know Forty-three years after Terry's Marathon of Hope, his dream of ending cancer through research remains alive thanks to the incredible efforts of Canadi...
Press Release|February 06, 2023 Outstanding early-career researchers will receive just over $2 million after winning 2023 Terry Fox New Investigator Award The Terry Fox Research Institute has named five promising early-career researchers as the recipients of the 2023 Terry Fox New Investigator Awards.
Press Release|November 29, 2022 Five outstanding research teams share $22.4 million in funding of two new and three renewal Terry Fox New Frontiers Program Project Grants in 2022 competition Five Canadian cancer research teams will share $22.4 million to expand their research into key areas of cancer treatment after winning the 2022 Terry ...
Press Release|November 29, 2022 The Terry Fox Research Institute and the Canadian Institutes of Health Research co-fund new, prestigious grant to tackle high-risk breast cancer A new partnership between the Terry Fox Research Institute (TFRI) and the Canadian Institutes of Health Research (CIHR) will enable a team of multidis...
Press Release|November 29, 2022 L’Institut de recherche Terry Fox et les Instituts de recherche en santé du Canada cofinancent une prestigieuse nouvelle subvention visant à s’attaquer au cancer du sein à haut risque En vertu d’un nouveau partenariat créé entre l’Institut de recherche Terry Fox (IRTF) et les Instituts de recherche en santé du Canada (IRSC), une équ...
Research Highlight|November 26, 2022 TFRI BC Node Research Day: Winning posters We're happy to announce the winning posters of the BC Cancer Summit-TFRI BC Node Research Day.
TFRI News|November 08, 2022 TFRI's 9th Scientific Meeting brings cancer researchers from across Canada to Vancouver Over 230 delegates representing all our TFRI-funded projects were at the event, which featured scientific presentations from principal investigators a...
Press Release|October 19, 2022 The Terry Fox Research Institute Opens New Office in Montreal Based at the Montreal Clinical Research Institute, the new office and team will play an important role as TFRI ramps up its research capacity and cont...
TFRI News|October 19, 2022 Un bureau montréalais pour l'Institut de recherche Terry Fox Le nouveau bureau et la nouvelle équipe de l'Institut de recherche Terry Fox (IRTF), basés à l'Institut de recherches cliniques de Montréal (IRCM), su...
Research Highlight|October 14, 2022 Researchers discover how deadly brain cancer evades treatments While each patient's MRD profile was found to be unique, the team was able to see how these unique features affected the trajectory to their cancer re...
TFRI News|October 05, 2022 Researchers break fundraising record, raise nearly $197k for research Scientists and clinicians funded by the TFRI showed up in full force for this year’s Terry Fox Run, raising over $123,000 for cancer research.
TFRI News|August 29, 2022 Support the 2022 Terry Fox Run Challenge The following teams have registered for this year's challenge. You can click on the link next to the team to donate to their run.
TFRI News|July 05, 2022 Launching the 2022 Terry Fox Run Challenge: A letter from Dr. Jim Woodgett The 2022 Terry Fox Run will take place on Sunday, Sept 18th, and it is my pleasure to invite you once again to register for the run and participate in...
Research Highlight|June 03, 2022 New clinical trial in dogs seeks to test innovative “seek and destroy” treatment that could bring new hope to pets and people with cancer A nanoparticle developed by TFRI-funded researchers is being used for the first time as part of an innovative clinical trial in dogs that could pave t...
TFRI News|May 06, 2022 Save the date: Upcoming TFRI events TFRI is pleased to provide this list of upcoming events offered and supported in 2021-2022. Visit the links provided for full details and to register.
News|May 06, 2022 TFRI News: Meet our newest team members A number of new employees have joined the Terry Fox Research Institute over the last few months. Here, we present our newest team members!
Research Highlight|May 06, 2022 Re-defining Li-Fraumeni Syndrome: A catchup with Dr. David Malkin, leader of the Terry Fox New Frontiers Program Project Team studying Li-Fraumeni Syndrome Over the last four years, the team has made significant findings that better help understand, diagnose, and potentially treat this cancer predispositi...
Research Highlight|May 06, 2022 Study identifies gaps in measuring symptom burden in Ontario adolescents and young adults with cancer A study by a Terry Fox New Investigator has revealed gaps in the provincial program designed to measure these symptoms in cancer patients.
Research Highlight|April 06, 2022 New study finds that location of immune cells is critical for immunotherapy response An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a patients’ response to immune therapy.
TFRI News|February 16, 2022 L'Institut de recherche Terry Fox annonce la nomination du Dr André Veillette au poste de directeur exécutif du Réseau des centres d’oncologie du Marathon de l'espoir L'Institut de recherche Terry Fox (IRTF) a le plaisir d'annoncer la nomination d'un éminent médecin et scientifique canadien, le Dr André Veillette, a...
Press Release|February 16, 2022 The Terry Fox Research Institute announces Dr. André Veillette as new Executive Director for the Marathon of Hope Cancer Centres Network The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of prominent Canadian physician-scientist, Dr. André Veillette, to the ...
Research Highlight|February 10, 2022 Gut bacteria linked to immune suppression in pancreatic cancer: Study Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...
TFRI News|February 03, 2022 Outstanding early-career researchers will receive $1.8 million after winning 2022 Terry Fox New Investigator Award Four promising, early-career scientists in Montreal, Toronto and Vancouver will each receive $450,000 over the next three years to support groundbreak...
Research Highlight|November 15, 2021 New prognostic biomarkers and cancer-driving genes found in the dark matter of the cancer genome Catalogue of 166 biomarkers generated through machine learning analysis of long non-coding RNAs
Research Highlight|November 01, 2021 TFRI hosts talk on the future of clinical trials featuring Dr. Elizabeth Eisenhauer Last Friday, October 29th, the TFRI hosted a virtual talk with Dr. Elizabeth Eisenhauer, professor emerita, oncology and medicine, Queen's University,...
Research Highlight|November 01, 2021 Lymphoma PPG team presents updates during first event of TFRI's Pan-Can Seminar Series Members of TFRI's BC-based Terry Fox New Frontiers Program Project Grant in Overcoming treatment failure in lymphoid cancers presented during the firs...
Research Highlight|November 01, 2021 EPPIC Researchers present in first Marathon of Hope Cancer Centres Network Seminar Series Researchers from TFRI's Enhanced Pancreatic Cancer Profiling for Individualized Care presented during the first event of the Marathon of Hope Cancer C...
TFRI News|October 25, 2021 Save the date: Upcoming events TFRI is pleased to provide this list of upcoming events offered and supported in 2021-2022. Visit the links provided for full details and to register.
TFRI News|October 22, 2021 Terry Fox Run Challenge: Researchers break fundraising record, raise nearly $125k for research Scientists and clinicians funded by the TFRI showed up in full force for this year’s Terry Fox Run, raising over $123,000 for cancer research.
Research Highlight|October 21, 2021 Study reveals a new target that suggests leukemia in children with Down syndrome could be prevented TFRI-funded researchers in Toronto have uncovered new information on the intricate relationship between the extra copy of chromosome 21 and leukemia, ...
Research Highlight|October 21, 2021 New study shows that exposure to ambient air pollution is a significant contributor to lung cancer among non-smokers Researchers from TFRI’s Pan-Can Lung Study team have pinpointed why more non-smokers are developing lung cancer, providing the basis for creating stra...
Research Highlight|October 21, 2021 TFRI-funded biobank used to make important findings that could help personalize and improve treatments for ovarian cancers Twelve years after it first received TFRI funding, the resource continues to be invaluable for researchers.
Research Highlight|October 21, 2021 New study reveals the genes that drive cancer in a subset of patients with medulloblastoma A new international study led by researchers partly funded by the TFRI has uncovered a number of genes that drive cancer in a subset of patients with ...
Research Highlight|October 21, 2021 Lymphoma team publishes two papers on diffuse large B-cell lymphoma in major journal Both papers help to better understand diffuse large B-cell lymphoma (DLBCL), a heterogeneous form of non-Hodgkin lymphoma that has an average five-yea...
Research Highlight|October 21, 2021 Study identifies that all cancers can be classified into two groups based on presence of YAP protein: Q&A with Dr. Rod Bremner A group of researchers partly funded by the TFRI has found that all cancers can be classified into two distinct groups based on the presence of a prot...
Research Highlight|October 21, 2021 RNA-seq is the best available tool to personalize treatment for patients with acute myeloid leukemia, study finds TFRI-funded researchers at BC Cancer in a new study demonstrate that a genomic test known as whole transcriptome sequencing (RNA-seq) is the best avai...
Research Highlight|September 10, 2021 New study helps understand who will benefit from immunotherapy TFRI-funded researchers at the Princess Margaret Cancer Centre in Toronto have made findings which help expand understanding of which patients will be...
TFRI News|August 30, 2021 TFRI launches 2021 Terry Fox Run Challenge The Terry Fox Research Institute (TFRI) is happy to launch its 2021 Terry Fox Run Challenge, an annual event in which our research teams look to claim...
TFRI News|August 19, 2021 The TFRI launches open call for white papers for the Marathon of Hope Cancer Centres Network The Terry Fox Research Institute (TFRI) is pleased to announce a first call for White Papers for the Marathon of Hope Cancer Centres Network (MOH...
Press Release|August 12, 2021 Les chercheurs de l’Atlantique unissent leurs forces et reçoivent 3,6 millions de dollars de nouveaux fonds provinciaux et nationaux pour accélérer la médecine de précision pour les patients atteints de cancer Pendant deux ans, le groupe collaborera dans un projet pilote commun dans le but de devenir membre à part entière du Réseau des centres d’oncologie du...
Press Release|August 12, 2021 Atlantic researchers join forces, receive $3.6 million in new provincial and national funding to accelerate precision medicine for cancer patients The group will work together under a joint pilot project over two years with the goal of becoming a full partner in the Terry Fox Research Institute’s...